No Detail Found!

Clopidogrel versus prasugrel in patients undergoingelective percutaneous coronary intervention

Author(s)
Shah Zeb Department of Cardiology Lady Reading Hospital Peshawar, Pakistan
Ibrahim Shah Department of Cardiology Lady Reading Hospital Peshawar, Pakistan
Mohammad Adil Department of Cardiology Lady Reading Hospital Peshawar, Pakistan
Jabar Ali Department of Cardiology Lady Reading Hospital Peshawar, Pakistan
Hikmatullah Jan Department of Cardiology Lady Reading Hospital Peshawar, Pakistan
Adnan Mahmood Gul Department of Cardiology Lady Reading Hospital Peshawar, Pakistan
Mohammad Hafizullah Khyber Medical University, Peshawar,Pakistan
Abstract
Objective: To compare short term clinical outcomes in patients on Clopidogrel and Prasugrel undergoing elective percutaneous coronary interventions. Methodology: This comparative study was conducted in Department of Cardiology department, Postgraduate Medical Institute Govt. Lady Reading Hospital Peshawar from 1st June 2012 to 31st March 2013. Patients undergoing elective PCI for significant lesions on coronary angiography of both genders having weight 60 Kg and baseline platelets aggregation of ≥5 ohm. All patients were followed for 1 month. Results: A total of 148 patients were included in the study. Group A had 74 patients using Clopidogrel and group B contained 74 patients using Prasugrel. Group A had 55 (74.3%) males while group B had 56 (75.7%) males (p=0.85). Mean age was 54.9±11.2 years in group A and 57.7±8.7 years in group B (p = 0.09). Mean percent difference between basal and follow up platelet aggregation was 52.96±24.77 ohm in group A and 82.25±14.34 ohm in group B (p= 0.001). At 01 month follow up 03 (4%) episodes of major bleeding occurred in Prasugrel group which led to discontinuation of the drug while minor bleeding episodes in 7 (9.5%) patients. There was NSTEMI ACS in 3 (4.1%) patients and STEMI in 01 (1.35%) in Clopidogrel group while 2 STEMI patients in Prasugrel group. Number of deaths were 2 in prasugrel group and 1 in clopidogrel group Composite of death, major bleeding, stroke, ACS was 7 (9.5%) in Prasugrel group and 6 (8%) in Clopidogrel group (p=0.09). Conclusion: There is no short term clinical benefit of Prasugrel over Clopidogrel in elective percutaneous coronary intervention.
Publication Details
Page(s) 107-112
DOI DOI not available
Published Journal: Pakistan Heart Journal, Volume: 49, Issue: 3, Year: 2016

Request the full text from PASTIC

Keywords
Percutaneous coronary intervention, clopidogrel, Bleeding, Prasugrel
0

Citations

0

Downloads

49

Views